Functional consequence and therapeutic targeting of cryptic ALK fusions in monosomy 7 acute myeloid leukemia von Manselle, Makia K., Ries, Rhonda E., Hylkema, Tiffany, Leonti, Amanda, Kirkey, Danielle C., Furlan, Scott N., Meshinchi, Soheil

Volltext

LAMP5 Is an AML-Restricted Immunotherapeutic Target Enriched in High-Risk Acute Myeloid Leukemia von Panahi, Nika, Hylkema, Tiffany, Hawkins, Grace, Manselle, Makia K, Peplinski, Jack H, Wallace, Logan K, Ries, Rhonda E, Meshinchi, Soheil, Kirkey, Danielle C

Volltext

Disease Monitoring in Acute Myeloid Leukemia with CLEC2A qRT-PCR von Manselle, Makia K, Kirkey, Danielle, Ries, Rhonda E, Hylkema, Tiffany, Panahi, Nika, Robinson, Leila, Wallace, Logan K, Peplinski, Jack H, Meshinchi, Soheil

Volltext

Functional Consequence and Therapeutic Targeting of Cryptic ALK Fusions (ALK fus) in Monosomy7 AML von Manselle, Makia K., Hylkema, Tiffany A., Leonti, Amanda R., Ries, Rhonda E., Le, Quy, Furlan, Scott N, Meshinchi, Soheil

Volltext

CLEC2A Is a Novel AML-Restricted Immunotherapeutic Target Enriched in KMT2A-Rearranged Acute Myeloid Leukemia von Kirkey, Danielle C, Robinson, Leila, Janssens, Derek, Hines, Margaret G, Hylkema, Tiffany, Manselle, Makia K, Ries, Rhonda E, Peplinski, Jack H, Wallace, Logan K, Otto, Dominik, Tarlock, Katherine, Henikoff, Steven, Li, Wei, Meshinchi, Soheil

Volltext